Collects safety reports on nonacog beta pegol in people with haemophilia B
Gathers side effect data from registries of haemophilia B patients treated with nonacog beta pegol.
Plain-language title generated from the registry record
Registry title: Adverse Event Data Collection From External Registries on Nonacog Beta Pegol
Key facts
- Where
- Sheffield, United KingdomSee the site
Where in United Kingdom
- European Haemophilia Safety Surveillance RegistrySheffield, United KingdomNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Novo Nordisk A/S
- Trial code
- NCT03690336
- Record updated
- 8 October 2026
- Original description
The purpose of this study is to collect data on adverse events from third party registries that include information about adverse events from patients with haemophilia B treated with nonacog beta pegol. The third party registries include PedNet Haemophilia Registry (PedNet) and the European Haemophilia Safety Surveillance System (EUHASS). Data from national and international registries in countries where nonacog beta pegol has been approved and marketed could be included in the data collection.Read full original descriptionShow less
Adverse Event Data Collection From External Registries on Nonacog Beta Pegol
The purpose of this study is to collect data on adverse events from third party registries that include information about adverse events from patients with haemophilia B treated with nonacog beta pegol. The third party registries include PedNet Haemophilia Registry (PedNet) and the European Haemophilia Safety Surveillance System (EUHASS). Data from national and international registries in countries where nonacog beta pegol has been approved and marketed could be included in the data collection.
Inclusion: Participation in the PedNet Registry and/or the European Haemophilia Safety Surveillance System (EUHASS), or other national and international registries.
Exclusion: Not applicable as this is a study collecting third-party data from registries.